MLLT10 and acute myeloid leukemia: Meanwhile, NUP98::NSD1, PICALM::MLLT10, and RUNX1::RUNX1T1 have a conserved breakpoint, representing 7.45%, 0.77%, and 13.64% of pediatric AML, respectively [49].